New Zealand’s Cannabis Legacy Genetics Reach Australian Medical Marijuana Market

New Zealand medical marijuana company  Rua Biosciences (NZE: RUA) announced Monday the launch of its dried flower called Rua Rau Hiwa in Australia. This is the Maori-born business’ first product launch into the Australian cannabis market.

Rua Rau Hiwa is derived from legacy genetics developed during the illegal cannabis cultivation era in the Tairāwhiti region.

“We are proud to offer Rua’s medicinal cannabis genetics sourced from New Zealand’s legacy market to thousands of patients across Australia,” Rua’s chief executive Paul Naske stated. “We continue to prioritize R&D and genetic discovery. Tairāwhiti is home to ‘legacy’ genetics developed over generations – it is these unique cannabis strains that are grown and discovered at Rua’s facility in Mangaoporo. “

Naske said the launch …

Full story available on Benzinga.com